| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.282 | 10.298 | 12.229 | 14.569 | 17.644 | 14.789 | 20.886 | 21.049 | 16.919 | 15.671 |
| Total Income - EUR | 15.338 | 10.299 | 12.456 | 15.267 | 17.686 | 14.789 | 20.887 | 21.049 | 16.919 | 15.671 |
| Total Expenses - EUR | 14.483 | 9.597 | 10.948 | 14.792 | 14.615 | 9.433 | 7.986 | 1.895 | 15.439 | 17.850 |
| Gross Profit/Loss - EUR | 854 | 702 | 1.507 | 475 | 3.071 | 5.356 | 12.900 | 19.155 | 1.480 | -2.180 |
| Net Profit/Loss - EUR | 395 | 496 | 1.382 | 323 | 2.894 | 5.263 | 12.725 | 18.523 | 1.295 | -2.650 |
| Employees | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Lotus Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 757 | 749 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.282 |
| Current Assets | 1.374 | 943 | 570 | 2.060 | 2.637 | 7.808 | 11.713 | 17.548 | 4.264 | 4.417 |
| Inventories | 397 | 423 | 416 | 409 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 10 | 0 | 0 | 0 | 11 | 122 | 15.207 | 0 | 0 |
| Cash | 977 | 510 | 154 | 1.651 | 2.637 | 7.798 | 11.591 | 2.341 | 4.264 | 4.417 |
| Shareholders Funds | 145 | 639 | 2.011 | 2.297 | 5.146 | 10.311 | 14.722 | 20.299 | 6.563 | 3.877 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.986 | 2.251 | 1.399 | 2.190 | 740 | 685 | 108 | 376 | 818 | 29.923 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Lotus Med Srl